Pancreatic Cancer
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreatic ductal adenocarcinoma (PDAC) is a disease of near uniform mortality”
From Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes (2019) · cites this paper as Hidalgo, 2010
In the citing paper
“About 50-75% of PDACs harbor p53 mutations.12”
From Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death (2013) · cites this paper as [12]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMoore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
Li, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,719
Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
Katz, M. H. G., Pisters, P. W. T., Evans, D. B., Sun, C. C., Lee, J. E., Fleming, J. B., Vauthey, N. J., Abdalla, E. K., Crane, C. H., Wolff, R. A., et al. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.12.020 · Cited by 827
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
Cunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2446 · Cited by 823
Regine, W. F., Winter, K. A., Abrams, R. A., Safran, H., Hoffman, J. P., Konski, A., Benson, A. B., Macdonald, J. S., Kudrimoti, M. R., Fromm, M. L., et al. (2008) · JAMA · doi:10.1001/jama.299.9.1019 · Cited by 755
Evans, D. B., Varadhachary, G. R., Crane, C. H., Sun, C. C., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Wang, H., Cleary, K. R., Staerkel, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8634 · Cited by 731
Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Chauffert, B., Mornex, F., Bonnetain, F., Rougier, P., Mariette, C., Bouché, O., Bosset, J. F., Aparicio, T., Mineur, L., Azzedine, A., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn281 · Cited by 696
Heinemann, V., Quietzsch, D., Gieseler, F., Gonnermann, M., Schönekäs, H., Rost, A., Neuhaus, H., Haag, C., Clemens, M., Heinrich, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1490 · Cited by 683
Epidemiology and risk factors for pancreatic cancer
Lowenfels, A. B., & Maisonneuve, P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.001 · Cited by 635
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mahadevan, D., & Von Hoff, D. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0686 · Cited by 601
Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K.-H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 581
Raut, C. P., Tseng, J. F., Sun, C. C., Wang, H., Wolff, R. A., Crane, C. H., Hwang, R., Vauthey, J.-N., Abdalla, E. K., Lee, J. E., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000259391.84304.2b · Cited by 564
Ferrone, C. R., Finkelstein, D. M., Thayer, S. P., Muzikansky, A., Castillo, C. F.-D., & Warshaw, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.3934 · Cited by 554
Huguet, F., André, T., Hammel, P., Artru, P., Balosso, J., Selle, F., Deniaud-Alexandre, E., Ruszniewski, P., Touboul, E., Labianca, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5663 · Cited by 529
Tempero, M., Plunkett, W., Ruiz van Haperen, V., Hainsworth, J., Hochster, H., Lenzi, R., & Abbruzzese, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.140 · Cited by 519
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Katz, M. H. G., Wang, H., Fleming, J. B., Sun, C. C., Hwang, R. F., Wolff, R. A., Varadhachary, G., Abbruzzese, J. L., Crane, C. H., Krishnan, S., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0295-2 · Cited by 480
Farrell, J. J., Elsaleh, H., Garcia, M., Lai, R., Ammar, A., Regine, W. F., Abrams, R., Benson, A. B., Macdonald, J., Cass, C. E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.067 · Cited by 458
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Heinemann, V., Boeck, S., Hinke, A., Labianca, R., & Louvet, C. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-82 · Cited by 434
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Ritchey, J., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007) · Cancer · doi:10.1002/cncr.22852 · Cited by 427
Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 406
ABO Blood Group and the Risk of Pancreatic Cancer
Wolpin, B. M., Chan, A. T., Hartge, P., Chanock, S. J., Kraft, P., Hunter, D. J., Giovannucci, E. L., & Fuchs, C. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp020 · Cited by 395
Herman, J. M., Swartz, M. J., Hsu, C. C., Winter, J., Pawlik, T. M., Sugar, E., Robinson, R., Laheru, D. A., Jaffee, E., Hruban, R. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8469 · Cited by 375
Self-citationBerger, A. C., Garcia, M., Hoffman, J. P., Regine, W. F., Abrams, R. A., Safran, H., Konski, A., Benson, A. B., MacDonald, J., & Willett, C. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6288 · Cited by 371
Slidell, M. B., Chang, D. C., Cameron, J. L., Wolfgang, C., Herman, J. M., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9587-1 · Cited by 362
Risk Factors for Pancreatic Cancer: Case-Control Study
Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J.-N., Pisters, P. W., Evans, D. B., Khan, R., Chou, T.-H., Lenzi, R., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01510.x · Cited by 331
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 317
Erkan, M., Reiser-Erkan, C., Michalski, C. W., Deucker, S., Sauliunaite, D., Streit, S., Esposito, I., Friess, H., & Kleeff, J. (2009) · Neoplasia · doi:10.1593/neo.81618 · Cited by 291
A Compendium of Potential Biomarkers of Pancreatic Cancer
Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D. N., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000046 · Cited by 288
Jimeno, A., Feldmann, G., Suárez-Gauthier, A., Rasheed, Z., Solomon, A., Zou, G.-M., Rubio-Viqueira, B., García-García, E., López-Ríos, F., Matsui, W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0924 · Cited by 276
Self-citationThe Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A., Petersen, G. M., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 275
Pawlik, T. M., Laheru, D., Hruban, R. H., Coleman, J., Wolfgang, C. L., Campbell, K., Ali, S., Fishman, E. K., Schulick, R. D., Herman, J. M., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9929-7 · Cited by 273
Molecular genetics of pancreatic intraepithelial neoplasia
Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
Faca, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050123 · Cited by 257
Hess, V., Glimelius, B., Grawe, P., Dietrich, D., Bodoky, G., Ruhstaller, T., Bajetta, E., Saletti, P., Figer, A., Scheithauer, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70001-9 · Cited by 239
Sultana, A., Tudur Smith, C., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., & Ghaneh, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603719 · Cited by 235
Shi, C., Hruban, R. H., & Klein, A. P. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.365 · Cited by 212
Signal transduction in pancreatic stellate cells
Masamune, A., & Shimosegawa, T. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0013-2 · Cited by 204
Alcohol Intake and Pancreatic Cancer Risk: A Pooled Analysis of Fourteen Cohort Studies
Genkinger, J. M., Spiegelman, D., Anderson, K. E., Bergkvist, L., Bernstein, L., van den Brandt, P. A., English, D. R., Freudenheim, J. L., Fuchs, C. S., Giles, G. G., et al. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0880 · Cited by 201
Regulation of T Cell Activation by Notch Ligand, DLL4, Promotes IL-17 Production and Rorc Activation
Mukherjee, S., Schaller, M. A., Neupane, R., Kunkel, S. L., & Lukacs, N. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804322 · Cited by 189
Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
Kulke, M. H., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Meyerhardt, J. A., Zhu, A. X., Enzinger, P. C., Kwak, E. L., Muzikansky, A., Lawrence, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8521 · Cited by 166
Ko, A. H., Hwang, J., Venook, A. P., Abbruzzese, J. L., Bergsland, E. K., & Tempero, M. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602687 · Cited by 165
Diagnosis of pancreatic cancer
Miura, F., Takada, T., Amano, H., Yoshida, M., Furui, S., & Takeshita, K. (2006) · HPB · doi:10.1080/13651820500540949 · Cited by 156
Loehrer, P. J., Powell, M. E., Cardenes, H. R., Wagner, L. I., Brell, J. M., Ramanathan, R., Crane, C. H., Alberts, S. R., & Benson, A. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4506 · Cited by 153
Xiong, H. Q., Varadhachary, G. R., Blais, J. C., Hess, K. R., Abbruzzese, J. L., & Wolff, R. A. (2008) · Cancer · doi:10.1002/cncr.23810 · Cited by 143
Hewish, M., Chau, I., & Cunningham, D. (2009) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489209787002515 · Cited by 141
Pancreatic head cancer: accuracy of CT in determination of resectability
Karmazanovsky, G. G., Fedorov, V. D., Va, K., & Kotchatkov, A. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0279-z · Cited by 138
Rubio-Viqueira, B., & Hidalgo, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.200 · Cited by 134
Self-citationShaib, Y. H., Davila, J. A., Naumann, C. R., & El‐Serag, H. B. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01202.x · Cited by 132
Landi, S. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.12.001 · Cited by 113
Bernhard, J., Dietrich, D., Scheithauer, W., Gerber, D., Bodoky, G., Ruhstaller, T., Glimelius, B. L. G., Bajetta, E., Schueller, J., Saletti, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6240 · Cited by 111
Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer
Wente, M. N., Jain, A., Kono, E., Berberat, P. O., Giese, T., Reber, H. A., Friess, H., B??chler, M. W., Reiter, R. E., & Hines, O. J. (2005) · Pancreas · doi:10.1097/01.mpa.0000173459.81193.4d · Cited by 94
Mayo, S. C., Austin, D. F., Sheppard, B. C., Mori, M., Shipley, D. K., & Billingsley, K. G. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.10.014 · Cited by 93
Chung, E. J., Brown, A. P., Asano, H., Mandler, M. D., Burgan, W. E., Carter, D., Camphausen, K. A., & Citrin, D. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2954 · Cited by 91
Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer
Rajeshkumar, N. V., Tan, A. C., De Oliveira, E., Womack, C., Wombwell, H., Morgan, S., Warren, M. V., Walker, J., Green, T. P., Jimeno, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3021 · Cited by 90
Self-citationVenous resection in pancreatic cancer surgery
Tseng, J. F., Tamm, E. P., Lee, J. E., Pisters, P. W. T., & Evans, D. B. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.11.003 · Cited by 84
Risk Factors for Pancreatic Cancer Mortality: Extended Follow-up of the Original Whitehall Study
Batty, G. D., Kivimäki, M., Morrison, D. S., Huxley, R., Smith, G. D., Clarke, R., Marmot, M. G., & Shipley, M. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1032 · Cited by 76
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice
Haklai, R., Elad‐Sfadia, G., Egozi, Y., & Kloog, Y. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0451-6 · Cited by 69
Current understanding of precursors to pancreatic cancer
Takaori, K. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1165-6 · Cited by 58
Screening of High-Risk Families for Pancreatic Cancer
Greenhalf, W., Grocock, C., Harcus, M., & Neoptolemos, J. P. (2009) · Pancreatology · doi:10.1159/000210262 · Cited by 58
Murugesan, S., King, C., Osborn, R., Fairweather, W., O'Reilly, E., Thornton, M., & Wei, L. L. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.32 · Cited by 57
Hernandez, J. M., Cowgill, S. M., Al-Saadi, S., Collins, A., Ross, S. B., Cooper, J., Villadolid, D., Zervos, E. E., & Rosemurgy, A. S. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0696-3 · Cited by 54
Zhang, W., Erkan, M., Abiatari, I., Giese, N. A., Felix, K., Kayed, H., Büchler, M. W., & Kleeff, J. H. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3623 · Cited by 54
Screening for Pancreatic Cancer in High-Risk Individuals: A Call for Endoscopic Ultrasound
Larghi, A., Verna, E. C., Lecca, P. G., & Costamagna, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1966 · Cited by 44
DeRosier, L. C., Vickers, S. M., Zinn, K. R., Huang, Z. Q., Wang, W., Grizzle, W. E., Sellers, J. C., Stockard, C. R., Zhou, T., Oliver, P. G., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0299 · Cited by 40
Pancreatic endoscopic retrograde cholangiopancreatography (ERCP)
Dumonceau, J., & Vonlaufen, A. (2007) · Endoscopy · doi:10.1055/s-2006-945096 · Cited by 15
Endoscopic evaluation and palliation of pancreatic adenocarcinoma: current and future options
Pausawasdi, N., & Scheiman, J. M. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282ba5713 · Cited by 14
Research works printed but not linked: 6
- Tersmette AC, 2001, Clin Cancer Res, 7, 738
- Hruban RH, 2008, Int J Clin Exp Pathol, 1, 306
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
- Li J, 2009, JOP, 10, 361
- Gold DV, 2003, Clin Cancer Res, 9, 3929S
- Hassan R, 2007, Cancer Immun, 7, 20
Cited by
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,586
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Metadata
- Authors
- Hidalgo, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Hidalgo, Manuel
- ORCID
- Hidalgo, Manuel
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-29
- Volume
- 362
- Issue
- 17
- Pages
- 1605-1617
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4244578979
- Cited by
- 2,570
- References
- 81
- Citations by year
- 2026: 53 · 2025: 68 · 2024: 79 · 2023: 109 · 2022: 138 · 2021: 162 · 2020: 198 · 2019: 194 · 2018: 199 · 2017: 225 · 2016: 221 · 2015: 225 · 2014: 247 · 2013: 189 · 2012: 143
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Keywords
- pancreatic cancer, pancreatic ductal adenocarcinoma, cancer mortality, pancreatic cancer management
- MeSH terms
- Gemcitabine, Antineoplastic Agents, Combined Modality Therapy, Deoxycytidine, Humans, Neoplasm Staging, Pancreatic Neoplasms, Risk Factors, Smoking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.